175 related articles for article (PubMed ID: 36519060)
21. Glycans as a key factor in self and nonself discrimination: impact on the breach of immune tolerance.
Alves I; Fernandes Â; Santos-Pereira B; Azevedo CM; Pinho SS
FEBS Lett; 2022 Jun; 596(12):1485-1502. PubMed ID: 35383918
[TBL] [Abstract][Full Text] [Related]
22. Generation of site-distinct N-glycan variants for in vitro bioactivity testing.
Brühlmann D; Vuillemin T; Satwekar A; Galano E; Palmese A; D'Angelo A; Manco Z; Souquet J; Broly H; Sauer M; Hemberger J; Jordan M
Biotechnol Bioeng; 2019 May; 116(5):1017-1028. PubMed ID: 30659587
[TBL] [Abstract][Full Text] [Related]
23. Transient CHO expression platform for robust antibody production and its enhanced N-glycan sialylation on therapeutic glycoproteins.
Zhong X; Ma W; Meade CL; Tam AS; Llewellyn E; Cornell R; Cote K; Scarcelli JJ; Marshall JK; Tzvetkova B; Figueroa B; DiNino D; Sievers A; Lee C; Guo J; Mahan E; Francis C; Lam K; D'Antona AM; Zollner R; Zhu HL; Kriz R; Somers W; Lin L
Biotechnol Prog; 2019 Jan; 35(1):e2724. PubMed ID: 30299005
[TBL] [Abstract][Full Text] [Related]
24. Multichannel DNA Sensor Array Fingerprints Cell States and Identifies Pharmacological Effectors of Catabolic Processes.
Das Saha N; Sasmal R; Meethal SK; Vats S; Gopinathan PV; Jash O; Manjithaya R; Gagey-Eilstein N; Agasti SS
ACS Sens; 2019 Dec; 4(12):3124-3132. PubMed ID: 31763818
[TBL] [Abstract][Full Text] [Related]
25. A Multichannel Biosensor for Rapid Determination of Cell Surface Glycomic Signatures.
Rana S; Le ND; Mout R; Duncan B; Elci SG; Saha K; Rotello VM
ACS Cent Sci; 2015 Jul; 1(4):191-197. PubMed ID: 26405691
[TBL] [Abstract][Full Text] [Related]
26. Controllability analysis of protein glycosylation in CHO cells.
St Amand MM; Tran K; Radhakrishnan D; Robinson AS; Ogunnaike BA
PLoS One; 2014; 9(2):e87973. PubMed ID: 24498415
[TBL] [Abstract][Full Text] [Related]
27. Identification of Fc Gamma Receptor Glycoforms That Produce Differential Binding Kinetics for Rituximab.
Hayes JM; Frostell A; Karlsson R; Müller S; Martín SM; Pauers M; Reuss F; Cosgrave EF; Anneren C; Davey GP; Rudd PM
Mol Cell Proteomics; 2017 Oct; 16(10):1770-1788. PubMed ID: 28576848
[TBL] [Abstract][Full Text] [Related]
28. Glycoengineering of Mammalian Expression Systems on a Cellular Level.
Heffner KM; Wang Q; Hizal DB; Can Ö; Betenbaugh MJ
Adv Biochem Eng Biotechnol; 2021; 175():37-69. PubMed ID: 29532110
[TBL] [Abstract][Full Text] [Related]
29. Constraints on the transport and glycosylation of recombinant IFN-gamma in Chinese hamster ovary and insect cells.
Hooker AD; Green NH; Baines AJ; Bull AT; Jenkins N; Strange PG; James DC
Biotechnol Bioeng; 1999 Jun; 63(5):559-72. PubMed ID: 10397812
[TBL] [Abstract][Full Text] [Related]
30. Understanding of decreased sialylation of Fc-fusion protein in hyperosmotic recombinant Chinese hamster ovary cell culture: N-glycosylation gene expression and N-linked glycan antennary profile.
Lee JH; Jeong YR; Kim YG; Lee GM
Biotechnol Bioeng; 2017 Aug; 114(8):1721-1732. PubMed ID: 28266015
[TBL] [Abstract][Full Text] [Related]
31. In Situ Cellular Glycan Analysis.
Chen Y; Ding L; Ju H
Acc Chem Res; 2018 Apr; 51(4):890-899. PubMed ID: 29595964
[TBL] [Abstract][Full Text] [Related]
32. Use of the serum glycan state to predict ovarian cancer patients' clinical response to chemotherapy treatment.
Zhao R; Lin G; Wang Y; Qin W; Gao T; Han J; Qin R; Pan Y; Sun J; Ren C; Ren S; Xu C
J Proteomics; 2020 Jul; 223():103752. PubMed ID: 32209427
[TBL] [Abstract][Full Text] [Related]
33. Lectin microarrays identify cell-specific and functionally significant cell surface glycan markers.
Tao SC; Li Y; Zhou J; Qian J; Schnaar RL; Zhang Y; Goldstein IJ; Zhu H; Schneck JP
Glycobiology; 2008 Oct; 18(10):761-9. PubMed ID: 18625848
[TBL] [Abstract][Full Text] [Related]
34. Glycan Labeling and Analysis in Cells and In Vivo.
Cheng B; Tang Q; Zhang C; Chen X
Annu Rev Anal Chem (Palo Alto Calif); 2021 Jul; 14(1):363-387. PubMed ID: 34314224
[TBL] [Abstract][Full Text] [Related]
35. An etanercept O-glycovariant with enhanced potency.
Biel TG; Faison T; Matthews AM; Zou G; Ortega-Rodriguez U; Pegues MA; Azer N; Gomez F; Johnson S; Rogstad S; Chen K; Xie H; Agarabi C; Rao VA; Ju T
Mol Ther Methods Clin Dev; 2022 Jun; 25():124-135. PubMed ID: 35402630
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of glycosylation on a camelid antibody uniquely affects its FcγRI binding activity.
Krahn N; Spearman M; Meier M; Dorion-Thibaudeau J; McDougall M; Patel TR; De Crescenzo G; Durocher Y; Stetefeld J; Butler M
Eur J Pharm Sci; 2017 Jan; 96():428-439. PubMed ID: 27721040
[TBL] [Abstract][Full Text] [Related]
37. Discrimination of Isomers of Released N- and O-Glycans Using Diagnostic Product Ions in Negative Ion PGC-LC-ESI-MS/MS.
Ashwood C; Lin CH; Thaysen-Andersen M; Packer NH
J Am Soc Mass Spectrom; 2018 Jun; 29(6):1194-1209. PubMed ID: 29603058
[TBL] [Abstract][Full Text] [Related]
38. Extensive determination of glycan heterogeneity reveals an unusual abundance of high mannose glycans in enriched plasma membranes of human embryonic stem cells.
An HJ; Gip P; Kim J; Wu S; Park KW; McVaugh CT; Schaffer DV; Bertozzi CR; Lebrilla CB
Mol Cell Proteomics; 2012 Apr; 11(4):M111.010660. PubMed ID: 22147732
[TBL] [Abstract][Full Text] [Related]
39. Differential carbohydrate binding and cell surface glycosylation of human cancer cell lines.
Arndt NX; Tiralongo J; Madge PD; von Itzstein M; Day CJ
J Cell Biochem; 2011 Sep; 112(9):2230-40. PubMed ID: 21480363
[TBL] [Abstract][Full Text] [Related]
40. N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression.
Holst S; Deuss AJ; van Pelt GW; van Vliet SJ; Garcia-Vallejo JJ; Koeleman CA; Deelder AM; Mesker WE; Tollenaar RA; Rombouts Y; Wuhrer M
Mol Cell Proteomics; 2016 Jan; 15(1):124-40. PubMed ID: 26537799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
